shoppernawer.blogg.se

Dxi beckman coulter
Dxi beckman coulter









dxi beckman coulter
  1. Dxi beckman coulter software#
  2. Dxi beckman coulter license#
  3. Dxi beckman coulter free#

The photos provided are given to display the overall condition of the equipment and all items found in the photos may not be included in the sale.

dxi beckman coulter

The written description provided for this equipment is what is being offered for sale.

Dxi beckman coulter license#

Typically any warranty, service contract or license for the equipment is not transferable but may be under certain circumstances and will be explicitly stated in the listing. The customer questioned the results as the results increased during the patients pregnancy. In regards to obtaining positive rubella igm results generated by unicel dxi 800 access immunoassay analyzer for one pregnant patient. It is encouraged that you inspect this equipment if possible. A customer contacted beckman coulter, inc. This Beckman Coulter UniCel DxI 800 is being sold “as is, where is” unless otherwise noted. The DxI 800 is easy enough for technologists of all skill levels to use, with industry-leading intuitive user interfaces and “load-and-go” simplicity that frees up staff for higher value work-no pausing or standby time required.įor more information visit the manufacture’s website where this information was provided: The reliable DxI 800 immunoassay analyzer is ready when you are, with low maintenance and improved performace. VERIS, DxI immunoassay instruments, DxC chemistry instruments. The Beckman Coulter UniCel DxI 800 Access Immunoassay System can run up to 400 tests in an hour. is a Danaher Corporation company that develops, manufactures and. All rights reserved.Description Beckman Coulter UniCel DxI 800 The Beckman Coulter DxI 800 immunoassay system meets most of these proposed goals, even though these clinically focused performance goals represent relatively stringent limits.Īnalytical performance Beckman Coulter DxI 800 Immunoassay Precision Quality control.Ĭopyright © 2014 The Canadian Society of Clinical Chemists. Beckman Coulter UniCel DxI 600 Access Immunoassay System - Like New Condition Efficient operation for exceptional productivity in the hospital lab Scale. Lot-to-lot consistency results for cortisol, ferritin and total thyroxine exceeded the proposed goals of 3.3%, 11.4% and 7% at one medical decision level, while vitamin B12 exceeded the proposed goals of 5.2% and 3.8% at two decision levels. All evaluated assays were within the proposed goals for instrument consistency.

Dxi beckman coulter free#

Carcinoembryonic antigen, total thyroxine and free triiodothyronine exceeded the proposed goals of ☖.3%, ±5% and ±5.7% for dilution linearity. Five assays had more than 15% of the test results below the minimum detection limits. Most of the assays met the proposed goals for precision (86% of intra-assay results and 75% of inter-assay results). for trueness and detection limits.Īll evaluated assays except total thyroxine were within the proposed goals for trueness. The changed sample type setting will reset to the previously saved setting when.

Dxi beckman coulter software#

If a default sample type setting on the tests screen is changed while running Unicel DXI system software version 4.3, the new setting is not saved to the system database.

dxi beckman coulter

Data were provided by Beckman Coulter, Inc. Class 2 Device Recall Beckman Coulter UniCel DxI 800. Local data were collected for precision, linearity, and consistency. We evaluated the analytical performance of 24 immunoassays using the Beckman Coulter DxI 800 immunoassay systems at Mayo Clinic, Rochester, MN for trueness, precision, detection limits, linearity, and consistency (across instruments and reagent lots).Ĭlinically oriented performance goals were defined using the following methods: trueness-published desirable accuracy limits, precision-published desirable biologic variation detection limits - 0.1 percentile of patient test values, linearity - 50% of total error, and consistency-percentage test values crossing key decision points.











Dxi beckman coulter